Cytoplasmic CD133 expression is a reliable prognostic indicator of tumor regression after neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer. (Q53160358)

From Wikidata

Jump to navigation Jump to search

scientific article published on 28 June 2012

Language	Label	Description	Also known as
English	Cytoplasmic CD133 expression is a reliable prognostic indicator of tumor regression after neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer.	scientific article published on 28 June 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

Cytoplasmic CD133 expression is a reliable prognostic indicator of tumor regression after neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

chemoradiotherapy

0 references

author name string

Shu-Wen Jao

1

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

Su-Feng Chen

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

Yaoh-Shiang Lin

3

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

Yun-Ching Chang

4

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

Tsai-Yu Lee

5

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

Chang-Chieh Wu

6

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

Jong-Shiaw Jin

7

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

Shin Nieh

8

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

publication date

28 June 2012

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

Annals of Surgical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

19

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

11

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

3432-3440

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Cancer stem cell-directed therapies: recent data from the laboratory and clinic

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Modern management of rectal cancer: a 2006 update

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Stem cells, cancer, and cancer stem cells

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Applying the principles of stem-cell biology to cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Tumour stem cells and drug resistance

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Mechanisms controlling pathogenesis and survival of leukemic stem cells

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Identification and expansion of human colon-cancer-initiating cells

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

CD133 expression is an independent prognostic marker for low survival in colorectal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Immunohistochemical features of CD133 expression: association with resistance to chemoradiotherapy in rectal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Tumor markers and colorectal cancer: utility in management

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Immunohistochemical detection of CD133 expression in colorectal cancer: a clinicopathological study.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Segregation of lipid raft markers including CD133 in polarized human hematopoietic stem and progenitor cells.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Leukocyte polarization in cell migration and immune interactions

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Cancer stem cell marker CD133+ tumour cells and clinical outcome in rectal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Significance of acellular mucin pools in rectal carcinoma after neoadjuvant chemoradiotherapy

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

A combined strategy of SAGE and quantitative PCR Provides a 13-gene signature that predicts preoperative chemoradiotherapy response and outcome in rectal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

CD44 is of Functional Importance for Colorectal Cancer Stem Cells

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2394-3

21 January 2018

Identifiers

10.1245/S10434-012-2394-3

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/22739652

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53160358&oldid=2212013599"